What is coog?
About Us
The Collaborative Ocular Oncology Group (COOG) is the largest collaborative working group in North America of ocular and medical oncologists specialized in the treatment of patients with intraocular cancers, currently focusing on uveal melanoma. The COOG comprises more than 25 leading academic and private ocular oncology centers of excellence and has been continually funded by the National Cancer Institute for over a decade. We have conducted two large multi-center prospective studies of prognostic biomarkers in uveal melanoma, the first and only such studies ever conducted in this cancer, and we are planning a major expansion into adjuvant and metastatic clinic trials in patients with uveal melanoma.
Our Mission
We are dedicated to a collaborative, evidence-based approach to advancing the care of patients with uveal melanoma and other eye cancers through precision diagnostic, prognostic, and therapeutic breakthroughs.
Our next directions
- Leverage existing infrastructure for interventional clinical trials
- Expand to include uveal melanoma medical oncologists
- Adjuvant trials using optimized prognostic tool from COOG2
- Use large COOG2 patient database for synthetic control
- Metastatic clinical trials using evidence based targets